AMDV Vaccine: Challenges and Perspectives

Area of Science:

• Veterinary Virology
• Animal Disease Epidemiology

Background:

• Aleutian mink disease virus (AMDV) is a globally prevalent pathogen causing significant economic losses in the mink industry.
• AMDV infection, leading to Aleutian disease (AD), is characterized by plasmacytosis and hyperglobulinemia, with current control relying on manual serological testing.
• The virus's persistent nature has hindered eradication efforts, making effective control strategies crucial for wildlife and industry protection.

Purpose of the Study:

• To review previous attempts at developing AMDV vaccines for mink.
• To summarize existing preventative measures against Aleutian disease (AD).
• To provide insights for future research on effective AMDV immunization strategies.

Main Methods:

• Literature review of scientific publications on AMDV vaccine development.
• Analysis of studies detailing immunization trials in mink.
• Compilation of data on various control and prevention strategies for Aleutian disease.

Main Results:

• Multiple research efforts have aimed to develop AMDV vaccines, with varying reported success in protecting mink.
• Despite numerous attempts, no commercially available vaccines currently exist for AMDV.
• Current control methods are limited, and the virus continues to spread.

Conclusions:

• The development of an effective AMDV vaccine is critical for controlling Aleutian disease.
• Further research into AMDV immunization is essential to protect the mink industry and wildlife.
• A comprehensive understanding of past efforts is necessary to design successful future preventative tools.